Role of Magnetic Resonance Spectroscopy in Evaluation of Congenital/Developmental Brain Abnormalities
Authors:
- Karuna ShekdarKSKaruna Shekdar
- Dah-Jyuu WangDWDah-Jyuu Wang
- 1 December 2011
- journal article
- Published by Elsevier in Seminars in Ultrasound, CT and MRI
- Vol. 32 (6) , 510-538
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Brain metabolite composition during early human brain development as measured by quantitative in vivo 1H magnetic resonance spectroscopyMagnetic Resonance in Medicine, 2002
- Developmental changes in choline- and ethanolamine-containing compounds measured with proton-decoupled31P MRS in in vivo human brainMagnetic Resonance in Medicine, 1999
- Early 1H Magnetic Resonance Spectroscopy of Acute Head Injury: Four CasesJournal of Neurotrauma, 1998
- In vivo detection of GABA in human brain using a localized double‐quantum filter techniqueMagnetic Resonance in Medicine, 1997
- Human cerebral osmolytes during chronic hyponatremia. A proton magnetic resonance spectroscopy study.Journal of Clinical Investigation, 1995
- Estimation of metabolite concentrations from localized in vivo proton NMR spectraMagnetic Resonance in Medicine, 1993
- Development of the human brain: In vivo quantification of metabolite and water content with proton magnetic resonance spectroscopyMagnetic Resonance in Medicine, 1993
- Effects of hypernatremia on organic brain osmoles.Journal of Clinical Investigation, 1990
- Spatial Localization in NMR Spectroscopy in VivoAnnals of the New York Academy of Sciences, 1987
- Spatial localization in 31P and 13C NMR spectroscopy in Vivo using surface coilsMagnetic Resonance in Medicine, 1984